Leaders in Oncology
By Mary Dominiecki, SVP, US Country Lead
August 13, 2025
In oncology, competition is intense and innovation moves fast. Leading companies are not only developing groundbreaking therapies but also excelling in building awareness, cultivating trust, and delivering meaningful patient support. Our most recent research, based on a survey of oncologists in the U.S. and Canada, sheds light on which pharmaceutical companies are perceived as leaders.
The data show that oncologists are most aware of large pharmaceutical companies with long-standing commitments in oncology, likely based on breadth and depth of exposure. Companies like AstraZeneca, Merck, and Pfizer consistently rank among the most recognized. For AstraZeneca and Merck, this is thanks in part to their early entry into the market with PD-1/PD-L1 inhibitors, which are now approved for the treatment of multiple tumor types. The success of AstraZeneca and Pfizer is further strengthened by a diverse oncology portfolio, spanning both solid tumors and hematologic malignancies.
Read More
Leadership is more than name recognition. Our research highlights a direct link between patient-centricity and perceived leadership. Not surprisingly, companies rated as most patient-focused are also those recognized for having the strongest patient support programs in oncology. This is not a coincidence. Oncologists notice when a company’s commitment to patient care goes beyond treatment to include comprehensive support systems. Such programs help patients navigate their treatment journey, improve adherence, and enhance overall outcomes. These are benefits that clinicians value deeply.
For pharmaceutical companies, these findings carry important implications. Competing effectively in oncology means not only advancing cutting-edge science but also building a brand that resonates with healthcare professionals and patients alike. Understanding how your company is perceived and how those perceptions stack up against competitors is critical to identifying where you can strengthen your position.
MD Analytics specializes in delivering actionable, data-driven insights tailored to the pharmaceutical industry. From measuring brand awareness and reputation to evaluating the impact of patient support initiatives, our research helps you pinpoint opportunities to elevate your strategy. With expertise in oncology and a deep understanding of healthcare professionals’ perspectives, we equip your teams with the intelligence needed to make informed, confident decisions.
Whether you are preparing to launch a new therapy, expand your portfolio, or reinforce your market leadership, our insights can guide you toward the strategies that make the biggest impact.
Contact us today to learn how we can help you transform market intelligence into competitive advantage in the oncology space.
Infographics may contain select findings from our Independent Studies. Contact us to find out if your organization qualifies for a complimentary presentation with access to the full report.
Past Studies
